
Opinion|Videos|June 2, 2025
Patient Education, Shared Decision-Making, and Optimizing Care for ESR1-Mutated Breast Cancer
Author(s)Virginia Kaklamani, MD, DSc, Megan Kruse, MD
Panelists discuss how a multidisciplinary team approach to patient education and medication management is crucial for ensuring adherence and optimal outcomes with oral medications like elacestrant.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Clinical Brief: Implementation and Patient Support Strategies
Main Discussion Topics:
- Role of multidisciplinary care team in patient education and support
- Importance of early intervention for side effect management
- Strategies for ensuring medication adherence with oral therapy
- Value of nurse coordinators and pharmacist integration
- Flexible approaches, including chemotherapy-endocrine therapy sequencing
Key Points for Physicians:
- Team-based approach crucial for successful oral therapy management
- Early touchpoints in first month prevent long-term discontinuation
- Patient education impacts adherence and anxiety management
- Consider short-course chemotherapy followed by endocrine therapy in select cases
- Communication protocols essential for optimal outcomes
The discussion highlighted that successful implementation of oral targeted therapies requires comprehensive support systems and proactive communication strategies to ensure optimal patient outcomes and treatment adherence.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5







































